Skip to main content
. 2026 Sep 2;15(17):1599. doi: 10.3390/cells15171599
Aβ amyloid-β
AD Alzheimer’s disease
ADP adenosine diphosphate
APOE apolipoprotein E
APP amyloid precursor protein
ARIA amyloid-related imaging abnormalities
AT(N) amyloid, tau, and neurodegeneration
ATP adenosine triphosphate
BACE β-site amyloid precursor protein-cleaving enzyme
BBB blood–brain barrier
CDR-SB clinical dementia rating-sum of boxes
CSF cerebrospinal fluid
Cyt c cytochrome c
DNA deoxyribonucleic acid
EEG electroencephalography
FDG-PET fluorodeoxyglucose positron emission tomography
FINGER Finnish Geriatric Intervention Study to Prevent Cognitive Impairment
and Disability
FMT fecal microbiota transplantation
GFAP glial fibrillary acidic protein
GWAS genome-wide association study
LATE limbic-predominant age-related TDP-43 encephalopathy
LDL low-density lipoprotein
MAPT microtubule-associated protein tau
MEG magnetoencephalography
MRI magnetic resonance imaging
NAFLD non-alcoholic fatty liver disease
NfL neurofilament light
NIA–AA National Institute on Aging–Alzheimer’s Association
PET positron emission tomography
PSEN presenilin
p-tau phosphorylated tau
RNA ribonucleic acid
ROS reactive oxygen species
SASP senescence-associated secretory phenotype
SCFAs short-chain fatty acids
TCA tricarboxylic acid
TDP-43 transactive response DNA-binding protein 43 kDa
TREM2 triggering receptor expressed on myeloid cells 2
Ub ubiquitin